Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison.
Saved in:
| Title: | Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison. |
|---|---|
| Authors: | Al-Qahtani, Mohammed H.1,2 (AUTHOR) mhalqahtani@kau.edu.sa, Assidi, Mourad1,2 (AUTHOR), Buhmeida, Abdelbaset1,2 (AUTHOR), Almuhammadi, Asma3 (AUTHOR), Pushparaj, Peter Natesan1,2 (AUTHOR), Alganmi, Nofe Ateq1,4 (AUTHOR) |
| Source: | PLoS ONE. 2/13/2026, Vol. 21 Issue 2, p1-33. 33p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 19326203 |
|---|---|
| DOI: | 10.1371/journal.pone.0341446 |
